R&D News | pharmaphorum

News

Merck KGaA has acknowledged that it is in talks to buy US cancer SpringWorks, but cautioned there is no guarantee a deal will be forthcoming.

News

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings.

News

A US judge has imposed a temporary injunction in 22 US states on the Trump administration's sweeping cuts to NIH funding of medical research.

News

Shares in Pliant plunged after the US biotech revealed that a safety signal led it to pause a trial of its idiopathic pulmonary fibrosis drug.

News

Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI.

News

Sionna has closed its IPO, raising $191m for cystic fibrosis candidates that it thinks could be more effective than rivals from Vertex.